Study to describe treatment patterns and outcomes in EGFRm NSCLC patients in Belgium

Trial Identifier: D5161R00007
Sponsor: AstraZeneca
NCTID:: NCT03761901
Start Date: September 2018
Primary Completion Date: June 2019
Study Completion Date: June 2019
Condition: Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Belgium Antwerpen, Belgium, 2020
Belgium Bouge, Belgium, 5004
Belgium Brussels, Belgium, 1090
Belgium Bruxelles, Belgium, 1200
Belgium Charleroi, Belgium, 6000
Belgium Edegem, Belgium, 2650
Belgium Gent, Belgium, 9000
Belgium Hasselt, Belgium, 3500
Belgium Mechelen, Belgium, 2800
Belgium Mons, Belgium, 7000
Belgium Roeselare, Belgium, 8800
Belgium Sint-Niklaas, Belgium, 9100
Belgium Sint-Truiden, Belgium, 3800
Belgium Turnhout, Belgium, 2300
Belgium Yvoir, Belgium, 5530